Very recent studies conducted in Europe demonstrated that elevated serum RANKL levels are associated with increased breast cancer risk among women with high progesterone levels [24], while another study reported that elevated OPG levels are associated with increased breast cancer risk [25]. The gene discussed is TNFSF11; the disease is breast carcinoma.